Skip Navigation


JAC Advance Access originally published online on June 14, 2005
Journal of Antimicrobial Chemotherapy 2005 56(2):344-348; doi:10.1093/jac/dki191
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/2/344    most recent
dki191v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gillespie, S. H.
Right arrow Articles by McHugh, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gillespie, S. H.
Right arrow Articles by McHugh, T. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates

Stephen H. Gillespie, Shreya Basu, Anne L. Dickens, Denise M. O'Sullivan and Timothy D. McHugh*

Centre for Medical Microbiology, University College London, Hampstead Campus, Rowland Hill St., London NW3 2PF, UK

Received 31 January 2005; returned 2 April 2005; revised 14 April 2005; accepted 12 May 2005

* Corresponding author. Tel: +44-20-7472-6402; Fax: +44-207-794-0433; E-mail: t.mchugh{at}medsch.ucl.ac.uk

Objectives: Fluoroquinolones have found a place in the management of mycobacterial diseases including tuberculosis. It has been previously shown that subinhibitory concentrations of quinolones increase the mutation rate in Escherichia coli and staphylococci. The purpose of this study is to extend this observation to mycobacteria and to quantify mutation rates.

Methods: The mutation rate in Mycobacterium fortuitum to ciprofloxacin, levofloxacin, moxifloxacin, rifampicin, erythromycin and gentamicin resistance was determined when grown with and without various sub-MIC concentrations of ciprofloxacin.

Results: M. fortuitum exposed to 1/2 MIC ciprofloxacin had an increase in the mutation rate of between 72- and 120-fold when selected on quinolones or other antimycobacterial antibiotics. Smaller, but significant increases in mutation rate were seen when the organism was exposed to lower concentrations (1/4 MIC and 1/8 MIC).

Conclusions: These data show that sub-MIC concentrations of fluoroquinolone significantly increase mutation rates and these data suggest that care must be taken to ensure that bacteria are not exposed to subinhibitory concentrations when adding quinolones to a regimen used to treat mycobacterial infection.

Keywords: fluoroquinolones , mycobacteria , quinolones , M. fortuitum


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
L. Becnel Boyd, M. J. Maynard, S. K. Morgan-Linnell, L. B. Horton, R. Sucgang, R. J. Hamill, J. R. Jimenez, J. Versalovic, D. Steffen, and L. Zechiedrich
Relationships among Ciprofloxacin, Gatifloxacin, Levofloxacin, and Norfloxacin MICs for Fluoroquinolone-Resistant Escherichia coli Clinical Isolates
Antimicrob. Agents Chemother., January 1, 2009; 53(1): 229 - 234.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. M. O'Sullivan, J. Hinds, P. D. Butcher, S. H. Gillespie, and T. D. McHugh
Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin
J. Antimicrob. Chemother., December 1, 2008; 62(6): 1199 - 1202.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
L. R. Mesak, V. Miao, and J. Davies
Effects of Subinhibitory Concentrations of Antibiotics on SOS and DNA Repair Gene Expression in Staphylococcus aureus
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3394 - 3397.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. F. Pope, D. M. O'Sullivan, T. D. McHugh, and S. H. Gillespie
A Practical Guide to Measuring Mutation Rates in Antibiotic Resistance
Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1209 - 1214.
[Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. F. Pope, S. H. Gillespie, J. R. Pratten, and T. D. McHugh
Fluoroquinolone-Resistant Mutants of Burkholderia cepacia
Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1201 - 1203.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
L. M. C. Hall and S. K. Henderson-Begg
Hypermutable bacteria isolated from humans - a critical analysis.
Microbiology, September 1, 2006; 152(Pt 9): 2505 - 2514.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. K. Henderson-Begg, D. M. Livermore, and L. M. C. Hall
Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniae
J. Antimicrob. Chemother., May 1, 2006; 57(5): 849 - 854.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.